IDEAS home Printed from https://ideas.repec.org/a/abf/journl/v60y2025i4p52856-52865.html

Biological Aspects of The Personalization Problem for Radiation Therapy in Glioblastoma Patients

Author

Listed:
  • Sergey Ivanov

    (Scientific Department of Carcinogenesis and Oncogerontology, Federal State Budgetary Institute N.N. Petrov National Medical Research Center of Oncology Ministry of Health of the Russian Federation, 197758, Saint Petersburg, Russia)

  • Alexander Chernov

    (Department of General Pathology and Pathological Physiology, Institute of Experimental Medicine, 197022, Saint Petersburg, Russia)

Abstract

Glioblastoma multiforme (GBM) is a very aggressive tumor of the central nervous system. In patients with this diagnosis, with contemporary treatment standards, life expectancy is about 15 months. Due to the inherent GBM heterogeneity, it is possible to personally improve the treatment outcomes for patients by individually predicting an adequate regime administration.

Suggested Citation

  • Sergey Ivanov & Alexander Chernov, 2025. "Biological Aspects of The Personalization Problem for Radiation Therapy in Glioblastoma Patients," Biomedical Journal of Scientific & Technical Research, Biomedical Research Network+, LLC, vol. 60(4), pages 52856-52865, February.
    • Handle: RePEc:abf:journl:v:60:y:2025:i:4:p:52856-52865
    DOI: 10.26717/BJSTR.2025.60.009486
    as

    Download full text from publisher

    File URL: https://biomedres.us/pdfs/BJSTR.MS.ID.009486.pdf
    Download Restriction: no
    File URL: https://biomedres.us/fulltexts/BJSTR.MS.ID.009486.php
    Download Restriction: no
    File URL: https://libkey.io/10.26717/BJSTR.2025.60.009486?utm_source=ideas
    LibKey link: if access is restricted and if your library uses this service, LibKey will redirect you to where you can use your library subscription to access this item
    ---><---

    References listed on IDEAS

    as
    1. Lucia Ricci-Vitiani & Roberto Pallini & Mauro Biffoni & Matilde Todaro & Gloria Invernici & Tonia Cenci & Giulio Maira & Eugenio Agostino Parati & Giorgio Stassi & Luigi Maria Larocca & Ruggero De Mar, 2010. "Tumour vascularization via endothelial differentiation of glioblastoma stem-like cells," Nature, Nature, vol. 468(7325), pages 824-828, December.
    2. Shideng Bao & Qiulian Wu & Roger E. McLendon & Yueling Hao & Qing Shi & Anita B. Hjelmeland & Mark W. Dewhirst & Darell D. Bigner & Jeremy N. Rich, 2006. "Glioma stem cells promote radioresistance by preferential activation of the DNA damage response," Nature, Nature, vol. 444(7120), pages 756-760, December.
    3. Rong Wang & Kalyani Chadalavada & Jennifer Wilshire & Urszula Kowalik & Koos E. Hovinga & Adam Geber & Boris Fligelman & Margaret Leversha & Cameron Brennan & Viviane Tabar, 2010. "Glioblastoma stem-like cells give rise to tumour endothelium," Nature, Nature, vol. 468(7325), pages 829-833, December.
    Full references (including those not matched with items on IDEAS)

    Most related items

    These are the items that most often cite the same works as this one and are cited by the same works as this one.
    1. Sree Deepthi Muthukrishnan & Riki Kawaguchi & Pooja Nair & Rachna Prasad & Yue Qin & Maverick Johnson & Qing Wang & Nathan VanderVeer-Harris & Amy Pham & Alvaro G. Alvarado & Michael C. Condro & Fuyin, 2022. "P300 promotes tumor recurrence by regulating radiation-induced conversion of glioma stem cells to vascular-like cells," Nature Communications, Nature, vol. 13(1), pages 1-19, December.
    2. Chenfei Lu & Tao Kang & Junxia Zhang & Kailin Yang & Yang Liu & Kefan Song & Qiankun Lin & Deobrat Dixit & Ryan C. Gimple & Qian Zhang & Zhumei Shi & Xiao Fan & Qiulian Wu & Daqi Li & Danyang Shan & J, 2025. "Combined targeting of glioblastoma stem cells of different cellular states disrupts malignant progression," Nature Communications, Nature, vol. 16(1), pages 1-21, December.
    3. Lata Adnani & Jordan Kassouf & Brian Meehan & Cristiana Spinelli & Nadim Tawil & Ichiro Nakano & Janusz Rak, 2022. "Angiocrine extracellular vesicles impose mesenchymal reprogramming upon proneural glioma stem cells," Nature Communications, Nature, vol. 13(1), pages 1-14, December.
    4. Eunnyung Bae & Ping Huang & Gaёlle Müller-Greven & Dolores Hambardzumyan & Andrew Edward Sloan & Amy S. Nowacki & Nicholas Marko & Cathleen R. Carlin & Candece L. Gladson, 2022. "Integrin α3β1 promotes vessel formation of glioblastoma-associated endothelial cells through calcium-mediated macropinocytosis and lysosomal exocytosis," Nature Communications, Nature, vol. 13(1), pages 1-15, December.
    5. Yingwen Ding & Ze-Yan Zhang & Ravesanker Ezhilarasan & Aram S. Modrek & Melanie Graciani & Jerome Karp & Graysen McManus & Ananya Jambhale & Erik P. Sulman, 2026. "NANP targeting radiosensitizes glioblastoma through TNFR1 sialylation-driven mesenchymal shift," Nature Communications, Nature, vol. 17(1), pages 1-18, December.
    6. Guiraldello, Rafael T. & Martins, Marcelo L. & Mancera, Paulo F.A., 2016. "Evaluating the efficacies of Maximum Tolerated Dose and metronomic chemotherapies: A mathematical approach," Physica A: Statistical Mechanics and its Applications, Elsevier, vol. 456(C), pages 145-156.
    7. Bianca L. Myers & Kathryn J. Brayer & Luis E. Paez-Beltran & Estrella Villicana & Matthew S. Keith & Hideaki Suzuki & Jessie Newville & Rebekka H. Anderson & Yunee Lo & Conner M. Mertz & Rahul K. Koll, 2024. "Transcription factors ASCL1 and OLIG2 drive glioblastoma initiation and co-regulate tumor cell types and migration," Nature Communications, Nature, vol. 15(1), pages 1-21, December.
    8. Qiuhong Zhu & Panpan Liang & Hao Meng & Fangzhen Li & Wei Miao & Cuiying Chu & Wei Wang & Dongxue Li & Cong Chen & Yu Shi & Xingjiang Yu & Yifang Ping & Chaoshi Niu & Hai-bo Wu & Aili Zhang & Xiu-wu B, 2024. "Stabilization of Pin1 by USP34 promotes Ubc9 isomerization and protein sumoylation in glioma stem cells," Nature Communications, Nature, vol. 15(1), pages 1-19, December.
    9. Lanjuan Mi & Yan Cai & Ji Qi & Lishu Chen & Yuanyuan Li & Songyang Zhang & Haowen Ran & Qinghui Qi & Cheng Zhang & Huiran Wu & Shuailiang Cao & Haohao Huang & Dake Xiao & Xinzheng Wang & Bohan Li & Ji, 2025. "Elevated nonhomologous end-joining by AATF enables efficient DNA damage repair and therapeutic resistance in glioblastoma," Nature Communications, Nature, vol. 16(1), pages 1-19, December.
    10. Paweł Wańkowicz & Przemysław Nowacki & Bogusław Machaliński & Dorota Rogińska, 2019. "Biomarkers of Cancer Stem Cells in Glioblastoma Multiforme and Histological Picture of Cancer," Biomedical Journal of Scientific & Technical Research, Biomedical Research Network+, LLC, vol. 23(3), pages 17365-17368, December.
    11. Francesco Antonica & Lucia Santomaso & Davide Pernici & Linda Petrucci & Giuseppe Aiello & Alessandro Cutarelli & Luciano Conti & Alessandro Romanel & Evelina Miele & Toma Tebaldi & Luca Tiberi, 2022. "A slow-cycling/quiescent cells subpopulation is involved in glioma invasiveness," Nature Communications, Nature, vol. 13(1), pages 1-15, December.
    12. Faye M. Walker & Lays Martin Sobral & Etienne Danis & Bridget Sanford & Sahiti Donthula & Ilango Balakrishnan & Dong Wang & Angela Pierce & Sana D. Karam & Soudabeh Kargar & Natalie J. Serkova & Nicho, 2024. "Rapid P-TEFb-dependent transcriptional reorganization underpins the glioma adaptive response to radiotherapy," Nature Communications, Nature, vol. 15(1), pages 1-21, December.
    13. Yonghua Li & Min Sheng & Weijie Li & Simin Liu & Botao Wang & Bing Liu & Mei Luo & Xiao Zhou & Qiaoxi Xia & Shihong Hong & Ziyuan Zheng & Shi-Yuan Cheng & Xiaobing Jiang & Junjun Li & Tianzhi Huang, 2026. "Targeting chaperone-mediated autophagy inhibits properties of glioblastoma stem cells and restores anti-tumor immunity," Nature Communications, Nature, vol. 17(1), pages 1-26, December.
    14. Davide Bernareggi & Qi Xie & Briana C. Prager & Jiyoung Yun & Luisjesus S. Cruz & Timothy V. Pham & William Kim & Xiqing Lee & Michael Coffey & Cristina Zalfa & Pardis Azmoon & Huang Zhu & Pablo Tamay, 2022. "CHMP2A regulates tumor sensitivity to natural killer cell-mediated cytotoxicity," Nature Communications, Nature, vol. 13(1), pages 1-14, December.
    15. Yan Zou & Yajing Sun & Yibin Wang & Dongya Zhang & Huiqing Yang & Xin Wang & Meng Zheng & Bingyang Shi, 2023. "Cancer cell-mitochondria hybrid membrane coated Gboxin loaded nanomedicines for glioblastoma treatment," Nature Communications, Nature, vol. 14(1), pages 1-19, December.
    16. Yuping Derek Li & David A. Giles & Yi Huang & Ashwani Kesarwani & Tong Hu & Logan Page & Amanda de Andrade Costa & Jingqin Luo & Alexandra Wolfarth & Donghoon Choi & Mai T. Dang & Albert H. Kim & John, 2026. "Long-acting interleukin-7 improves the efficacy of oncolytic viral therapy in glioblastoma," Nature Communications, Nature, vol. 17(1), pages 1-15, December.
    17. Min Kyung Lee & Nasim Azizgolshani & Joshua A. Shapiro & Lananh N. Nguyen & Fred W. Kolling & George J. Zanazzi & Hildreth Robert Frost & Brock C. Christensen, 2024. "Identifying tumor type and cell type-specific gene expression alterations in pediatric central nervous system tumors," Nature Communications, Nature, vol. 15(1), pages 1-14, December.
    18. Crismita Dmello & Junfei Zhao & Li Chen & Andrew Gould & Brandyn Castro & Victor A. Arrieta & Daniel Y. Zhang & Kwang-Soo Kim & Deepak Kanojia & Peng Zhang & Jason Miska & Ragini Yeeravalli & Karl Hab, 2023. "Checkpoint kinase 1/2 inhibition potentiates anti-tumoral immune response and sensitizes gliomas to immune checkpoint blockade," Nature Communications, Nature, vol. 14(1), pages 1-18, December.
    19. Weiwei Lin & Rui Niu & Seong-Min Park & Yan Zou & Sung Soo Kim & Xue Xia & Songge Xing & Qingshan Yang & Xinhong Sun & Zheng Yuan & Shuchang Zhou & Dongya Zhang & Hyung Joon Kwon & Saewhan Park & Chan, 2023. "IGFBP5 is an ROR1 ligand promoting glioblastoma invasion via ROR1/HER2-CREB signaling axis," Nature Communications, Nature, vol. 14(1), pages 1-16, December.
    20. Michelle M. Kameda-Smith & Helen Zhu & En-Ching Luo & Yujin Suk & Agata Xella & Brian Yee & Chirayu Chokshi & Sansi Xing & Frederick Tan & Raymond G. Fox & Ashley A. Adile & David Bakhshinyan & Kevin , 2022. "Characterization of an RNA binding protein interactome reveals a context-specific post-transcriptional landscape of MYC-amplified medulloblastoma," Nature Communications, Nature, vol. 13(1), pages 1-19, December.

    More about this item

    Keywords

    ;
    ;
    ;
    ;
    ;
    ;
    ;
    ;
    ;
    ;
    ;

    JEL classification:

    • R00 - Urban, Rural, Regional, Real Estate, and Transportation Economics - - General - - - General
    • Z0 - Other Special Topics - - General

    Statistics

    Access and download statistics

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:abf:journl:v:60:y:2025:i:4:p:52856-52865. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    If CitEc recognized a bibliographic reference but did not link an item in RePEc to it, you can help with this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Angela Roy (email available below). General contact details of provider: .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.